Cargando…

Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin

Exosomes are small extracellular membrane vesicles of endocytic origin released by many cells that could be found in most body fluids. The main functions of exosomes are cellular communication and cellular waste clean-up. This study was conducted to determine the involvement of exosomes in the regul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Xia, Yu, Shaorong, Li, Shuchun, Wu, Jianzhong, Ma, Rong, Cao, Haixia, Zhu, Yanliang, Feng, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931805/ https://www.ncbi.nlm.nih.gov/pubmed/24586853 http://dx.doi.org/10.1371/journal.pone.0089534

Ejemplares similares

Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR‐TKI treatment
por: Cao, Haixia, et al.
Publicado: (2016)

Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis
por: Liu, Yun, et al.
Publicado: (2015)

Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes
por: Qin, Xiaobing, et al.
Publicado: (2017)

Tumor-derived exosomes in cancer progression and treatment failure
por: Yu, Shaorong, et al.
Publicado: (2015)

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
por: Qin, Xiaobing, et al.
Publicado: (2017)

Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
por: Ma, Rong, et al.
Publicado: (2020)

LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation
por: Liu, Siwen, et al.
Publicado: (2018)

Reversal of multidrug resistance by cisplatin-loaded magnetic Fe(3)O(4) nanoparticles in A549/DDP lung cancer cells in vitro and in vivo
por: Li, Ke, et al.
Publicado: (2013)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells
por: He, Saifei, et al.
Publicado: (2021)

CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway
por: Feng, Sitong, et al.
Publicado: (2023)

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
por: Bian, Hai-Bo, et al.
Publicado: (2011)

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro
por: Hu, Yong, et al.
Publicado: (2017)

3′,4′,5′,5,7-Pentamethoxyflavone Sensitizes Cisplatin-Resistant A549 Cells to Cisplatin by Inhibition of Nrf2 Pathway
por: Hou, Xiangyu, et al.
Publicado: (2015)

Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
por: Gao, Jin, et al.
Publicado: (2020)

Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro
por: Lou, Rui, et al.
Publicado: (2019)

CDCA4 suppresses epithelial–mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy
por: Xu, Chenxin, et al.
Publicado: (2021)

Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
por: Gao, Jin, et al.
Publicado: (2021)

Mannose Impairs Lung Adenocarcinoma Growth and Enhances the Sensitivity of A549 Cells to Carboplatin
por: Sha, Jun, et al.
Publicado: (2020)

MiTF is Associated with Chemoresistance to Cisplatin in A549 Lung Cancer Cells via Modulating Lysosomal Biogenesis and Autophagy
por: Li, Wei, et al.
Publicado: (2020)

Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells
por: Huang, Cian-Song, et al.
Publicado: (2018)

Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells
por: Hu, Bo, et al.
Publicado: (2020)

RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis
por: ZHAO, XIAOZHEN, et al.
Publicado: (2015)

Screening miRNAs associated with resistance gemcitabine from exosomes in A549 lung cancer cells
por: Liang, Ai-Ling, et al.
Publicado: (2019)

Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH
por: Jing, Changwen, et al.
Publicado: (2020)

Edaravone Decreases Paraquat Toxicity in A549 Cells and Lung Isolated Mitochondria
por: Shokrzadeh, Mohammad, et al.
Publicado: (2014)

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
por: Gao, Yanyun, et al.
Publicado: (2019)

LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
por: Zhao, Xia, et al.
Publicado: (2018)

Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021)

Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer
por: ZHU, YING, et al.
Publicado: (2014)

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
por: Ni, Jie, et al.
Publicado: (2018)

Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer
por: Ma, Rong, et al.
Publicado: (2017)

Tripchlorolide induces autophagy in lung cancer cells by inhibiting the PI3K/AKT/mTOR pathway and improves cisplatin sensitivity in A549/DDP cells
por: Chen, Li-Min, et al.
Publicado: (2017)

Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
por: Gao, Zhao-jia, et al.
Publicado: (2018)

Radiosensitization effects of curcumin plus cisplatin on non-small cell lung cancer A549 cells
por: Cai, Yong, et al.
Publicado: (2019)

Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells
por: Horibe, Sayo, et al.
Publicado: (2022)

Overexpression of xeroderma pigmentosum group C decreases the chemotherapeutic sensitivity of colorectal carcinoma cells to cisplatin
por: Zhang, Yi, et al.
Publicado: (2018)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cadm74eakbjk51o3et0624g1rg